Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Metabolic Brain Disease
Published in: Metabolic Brain Disease 6/2018

01-12-2018 | Original Article

Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach

Authors: P. Sneha, Tanzila U. Zenith, Ummay Salma Abu Habib, Judith Evangeline, D. Thirumal Kumar, C. George Priya Doss, R. Siva, Hatem Zayed

Published in: Metabolic Brain Disease | Issue 6/2018

Login to get access

Abstract

Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by the mutations in survival motor neuron 1 gene (SMN1). The molecular pathology of missense mutations in SMN1 is not thoroughly investigated so far. Therefore, we collected all missense mutations in the SMN1 protein, using all possible search terms, from three databases (PubMed, PMC and Google Scholar). All missense mutations were subjected to in silico pathogenicity, conservation, and stability analysis tools. We used statistical analysis as a QC measure for validating the specificity and accuracy of these tools. PolyPhen-2 demonstrated the highest specificity and accuracy. While PolyPhen-1 showed the highest sensitivity; overall, PolyPhen2 showed better measures in comparison to other in silico tools. Three mutations (D44V, Y272C, and Y277C) were identified as the most pathogenic and destabilizing. Further, we compared the physiochemical properties of the native and the mutant amino acids and observed loss of H-bonds and aromatic stacking upon the cysteine to tyrosine substitution, which led to the loss of aromatic rings and may reduce protein stability. The three mutations were further subjected to Molecular Dynamics Simulation (MDS) analysis using GROMACS to understand the structural changes. The Y272C and Y277C mutants exhibited maximum deviation pattern from the native protein as compared to D44V mutant. Further MDS analysis predicted changes in the stability that may have been contributed due to the loss of hydrogen bonds as observed in intramolecular hydrogen bond analysis and physiochemical analysis. A loss of function/structural impact was found to be severe in the case of Y272C and Y277C mutants in comparison to D44V mutation. Correlating the results from in silico predictions, physiochemical analysis, and MDS, we were able to observe a loss of stability in all the three mutants. This combinatorial approach could serve as a platform for variant interpretation and drug design for spinal muscular dystrophy resulting from missense mutations.
Literature
Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chapter 7:Unit7.20
Agrahari AK, Kumar A, Sneha P, Zayed H, George Priya Doss C (2018a) Substitution impact of highly conserved arginine residue at position 75 in GJB1 gene in association with X-linked Charcot-Marie-tooth disease: A computational study. J Theor Biol 437:305–317CrossRef
Ali SK, Sneha P, Priyadharshini Christy J, Zayed H, George Priya Doss C (2017) Molecular dynamics-based analyses of the structural instability and secondary structure of the fibrinogen gamma chain protein with the D356V mutation. J Biomol Struct Dyn 35(12):2714–2724CrossRef
Alías L, Bernal S, Fuentes-Prior P, Barceló MJ, Also E, Martínez-Hernández R, Rodríguez-Alvarez FJ, Martín Y, Aller E, Grau E, Peciña A, Antiñolo G, Galán E, Rosa AL, Fernández-Burriel M, Borrego S, Millán JM, Hernández-Chico C, Baiget M, Tizzano EF (2008) Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet 125(1):29–39CrossRef
Azzouz M, Le T, Ralph GS, Walmsley L, Monani UR, Lee DC, Wilkes F, Mitrophanous KA, Kingsman SM, Burghes AH, Mazarakis ND (2004) Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy. J Clin Invest 114:1726–1731CrossRef
Brichta L, Garbes L, Jedrzejowska M, Grellscheid SN, Holker I, Zimmermann K, Wirth B (2008) Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy. Hum Genet 123:141e153CrossRef
Briese M, Esmaeili B, Fraboulet S, Burt EC, Christodoulou S, Towers PR, Davies KE, Sattelle DB (2009) Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan. Hum Mol Genet 18:97–104CrossRef
Capriotti E, Calabrese R, Casadio R (2006) Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729–2734CrossRef
Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306–W310CrossRef
Chen C-W, Lin J, Chu Y-W (2013) iStable: off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics 14 Suppl 2:S5CrossRef
Cheng J, Randall A, Baldi P (2006) Prediction of protein stability changes for single-site mutations using support vector machines. Proteins 62:1125–1132CrossRef
Chiriboga CA (2017) Nusinersen for the treatment of spinal muscular atrophy. Expert Rev Neurother 17:955–962CrossRef
Doss CG, Alasmar DR, Bux RI, Sneha P, Bakhsh FD, Al-Azwani I, Bekay RE, Zayed H (2016) Genetic Epidemiology of Glucose-6-Dehydrogenase Deficiency in the Arab World. Sci Rep 17(6):37284CrossRef
Ebert AD, Yu J, Rose FF Jr, Mattis VB, Lorson CL, Thomson JA, Svendsen CN (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457:277–280CrossRef
Eleni Z, Martin T, Wirth B, Yilmaz U, Gortner L, Meyer S (2015) Tongue fasciculations in an infant with spinal muscular atrophy type 1. Clinical Case Reports 3(10):832–834CrossRef
Finkel RS, Crawford TO, Swoboda KJ, Kaufmann P, Juhasz P, Li X, Guo Y, Li RH, Trachtenberg F, Forrest SJ, Kobayashi DT, Chen KS, Joyce CL, Plasterer T; Pilot Study of Biomarkers for Spinal Muscular Atrophy Trial Group (2012) Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study. Winkler C, ed. PLoS ONE. 7(4):e35462
Frugier T, Nicole S, Cifuentes-Diaz C, Melki J (2002) The molecular bases of spinal muscular atrophy. Curr Opin Genet Dev 12:294–298CrossRef
George Priya Doss C, Chakraborty C, Haneef SA, Nagasundaram N, Chen L, Zhu H (2014) Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2). Theranostics 4:366–385CrossRef
George Priya Doss C, Rajith B (2013) A new insight into structural and functional impact of single-nucleotide polymorphisms in PTEN gene. Cell Biochem Biophys 66:249–263CrossRef
George Priya Doss C, Zayed H (2017) Comparative computational assessment of the pathogenicity of mutations in the Aspartoacylase enzyme. Metab Brain Dis 32:2105–2118CrossRef
Glaser F, Pupko T, Paz I, Bell RE, Bechor-Shental D, Martz E, Ben-Tal N (2003) ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19:163–164CrossRef
Gopalakrishnan C, Jethi S, Kalsi N, Purohit R (2016) Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight. Cell Biochem Biophys 74(2):129–139CrossRef
Gopalakrishnan C, Kalsi N, Jethi S, Purohit R (2015) Computational investigation of molecular mechanism and neuropathological implications in Huntington disease. Mol Cell Biochem 409(1–2):1–11CrossRef
Gubitz AK, Feng W, Dreyfuss G (2004) The SMN complex. Exp Cell Res 296(1):51–56CrossRef
Hamilton G, Gillingwater TH (2013) Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med 19:40–50CrossRef
Havens MA, Duelli DM, Hastings ML (2013) Targeting RNA splicing for disease therapy. Wiley Interdiscip Rev RNA 4:247–266CrossRef
Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, de Bakker PI (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24:2938–2939CrossRef
Kamaraj B, Purohit R (2016) Mutational Analysis on Membrane Associated Transporter Protein (MATP) and Their Structural Consequences in Oculocutaeous Albinism Type 4 (OCA4)-A Molecular Dynamics Approach. J Cell Biochem 117(11):2608–2619CrossRef
Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ (2015) The Phyre2 web portal for protein modeling, prediction and analysis. Nat Protoc 10(6):845–858CrossRef
Kolb SJ, Kissel JT (2015) Spinal muscular atrophy. Neurol Clin 33(4):831–846CrossRef
Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 16:265–269CrossRef
Li W (2017) How do SMA-linked mutations of SMN1 lead to structural/functional deficiency of the SMA protein? PLoS One 12(6):e0178519CrossRef
Markowitz JA, Singh P, Darras BT (2012) Spinal muscular atrophy: a clinical and research update. Pediatr Neurol 46:1–12CrossRef
Monani UR (2005) Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor-neuron specific disease. Neuron 48(6):885–896CrossRef
Mosaeilhy A, Mohamed MM, George Priya Doss C, El Abd HSA, Gamal R, Zaki OK, Zayed H (2017) Genotype-phenotype correlation in 18 Egyptian patients with glutaric acidemia type I. Metab Brain Dis 32:1417–1426CrossRef
Mourelatos Z, Abel L, Yong J, Kataoka N, Dreyfuss G (2001) SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J 20:5443–5452CrossRef
Mulcahy PJ, Iremonger K, Karyka E, Herranz-Martín S, Shum KT, Tam JK, Azzouz M (2014) Gene Therapy: A Promising Approach to Treating Spinal Muscular Atrophy. Hum Gene Ther 25:575–586CrossRef
Palladino A, Passamano L, Taglia A, D'Ambrosio P, Scutifero M, Cecio MR, Picillo E, Viggiano E, Torre V, De Luca F, Nigro G, Politano L (2011) Cardiac involvement in patients with Spinal Muscular Atrophies. Acta Myologica 30(3):175–178PubMedPubMedCentral
Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95:615–624CrossRef
Qu YJ, Bai JL, Cao YY, Wang H, Jin YW, Du J, Ge XS, Zhang WH, Li Y, He SX, Song F (2016) Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy. J Mol Diagn 18(5):741–752CrossRef
Rajendran V (2016) Structural analysis of oncogenic mutation of isocitrate dehydrogenase 1. Mol BioSyst 12(7):2276–2287CrossRef
Rajendran V, Gopalakrishnan C, Purohit R (2016) Impact of point mutation P29S in RAC1 on tumorigenesis. Tumour Biol 37(11):15293–15304CrossRef
Rajendran V, Gopalakrishnan C, Sethumadhavan R (2018) Pathological role of a point mutation (T315I) in BCR-ABL1 protein-A computational insight. J Cell Biochem 119(1):918–925CrossRef
Sneha P, Doss CGP (2017) Chapter Nine - Elucidating the Mutational Landscape in Hepatocyte Nuclear Factor 1β (HNF1B) by Computational Approach. 2017. Chapter Nine - Elucidating the Mutational Landscape in Hepatocyte Nuclear Factor 1β (HNF1B) by Computational Approach. Adv Protein Chem Struct Biol 107:283–306CrossRef
Sneha P, George Priya Doss C (2016) Chapter Seven – Molecular Dynamics: New Frontier in Personalized Medicine. In: Advances in Protein Chemistry and Structural Biology. pp 181–224
Sneha P, Thirumal Kumar D, George Priya Doss C, Siva R, Zayed H (2017a) Determining the role of missense mutations in the POU domain of HNF1A that reduce the DNA-binding affinity: A computational approach. PLoS One 12:e0174953CrossRef
Sneha P, Thiurmal Kumar D, Tanwar H, Siva R, George Priya Doss C, Zayed H (2017b) Structural Analysis of G1691S Variant in the Human Filamin B Gene Responsible for Larsen Syndrome: A Comparative Computational Approach. J Cell Biochem 118(7):1900–1910CrossRef
Stone EA, Sidow A (2005) Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 15:978–986CrossRef
Sugarman EA, Nagan N, Zhu H, Akmaev VR, Zhou Z, Rohlfs EM, Flynn K, Hendrickson BC, Scholl T, Sirko-Osadsa DA, Allitto BA (2012) Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of 472 400 specimens. Eur J Hum Genet 20:27–32CrossRef
Sun Y, Grimmler M, Schwarzer V, Schoenen F, Fischer U, Wirth B (2005) Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy. Hum Mutat 25:64e71CrossRef
Thirumal Kumar D, Sneha P, Uppin J, Usha S, George Priya Doss C (2018) Investigating the Influence of Hotspot Mutations in Protein-Protein Interaction of IDH1 Homodimer Protein: A Computational Approach. Adv Protein Chem Struct Biol 111:243–261CrossRef
Workman E, Kolb SJ, Battle DJ (2012) Spliceosomal small nuclear ribonucleoprotein biogenesis defects and motor neuron selectivity in spinal muscular atrophy. Brain Res 1462:93–99CrossRef
Yu-jin Q, Juan D, Er-zhen L, Jin-li B, Yu-wei J, Hong W, Fang S et al (2012) Subtle mutations in the SMN1 gene in Chinese patients with SMA: p.Arg288Met mutation is causing SMN1 transcript exclusion of exon7. BMC Med Genet 13:86CrossRef
Yun S, Guy HR (2011) Stability tests on known and misfolded structures with discrete and all-atom molecular dynamics simulations. J Mol Graph Model 29(5):663–675CrossRef
Zaki OK, George Priya Doss C, Ali SA, Murad GG, Elashi SA, Ebnou MSA, Kumar DT, Khalifa O, Gamal R, El Abd HSA, Nasr BN, Zayed H (2017) Genotype-phenotype correlation in patients with isovaleric acidaemia: comparative structural modelling and computational analysis of novel variants. Hum Mol Genet 26:3105–3115PubMed
Metadata
Title
Impact of missense mutations in survival motor neuron protein (SMN1) leading to Spinal Muscular Atrophy (SMA): A computational approach
Authors
P. Sneha
Tanzila U. Zenith
Ummay Salma Abu Habib
Judith Evangeline
D. Thirumal Kumar
C. George Priya Doss
R. Siva
Hatem Zayed
Publication date
01-12-2018
Publisher
Springer US
Published in
Metabolic Brain Disease / Issue 6/2018
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-018-0285-4

Other articles of this Issue 6/2018

Metabolic Brain Disease 6/2018 Go to the issue

Original Article

EGb761 improves the cognitive function of elderly db/db−/− diabetic mice by regulating the beclin-1 and NF-κB signaling pathways

Original Article

Oxymatrine attenuates brain hypoxic-ischemic injury from apoptosis and oxidative stress: role of p-Akt/GSK3β/HO-1/Nrf-2 signaling pathway

Original Article

Nicotinamide reverses behavioral impairments and provides neuroprotection in 3˗nitropropionic acid induced animal model ofHuntington’s disease: implication of oxidative stress˗ poly(ADP˗ ribose) polymerase pathway

Correction

Correction to: Therapeutic effects of probiotics on neurotoxicity induced by clindamycin and propionic acid in juvenile hamsters

Original Article

Contourlet-based hippocampal magnetic resonance imaging texture features for multivariant classification and prediction of Alzheimer’s disease

Commentary

Reply to ‘contribution of the MRPS22 variant and a down mosaic to the phenotype’